Overall rank by patents
#30,790
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Aramis Biotechnologies Inc.
USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
8
Total patents granted
6
CPC technology areas
17.0
Avg claims per patent
-
5-year filing velocity
The verdict
Aramis holds 8 US patents across 6 technology areas, rank #30,790 of 50,000 tracked assignees.
- #30,790
- of 50,000 US assignees by volume
- Top 21%
- by Innovation Score (46.5/100)
- 17.0
- avg claims per patent
Portfolio overview
Aramis Biotechnologies Inc. has been granted 8 US utility patents between 2024 and 2025, placing Aramis Biotechnologies Inc. at rank #30,790 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.0 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Aramis Biotechnologies Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Aramis sits between APM Automation Solutions Ltd (8 patents, rank #30,786) and ARK Limited (8 patents, rank #30,794) - the closest US assignees by grant volume. The composite Innovation Score of 46.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Aramis Biotechnologies Inc.'s 17.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Aramis Biotechnologies Inc. against peers pursuing similar technology classes.
Who files at Aramis's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- APM Automation So…
APM AUTOMATION SOLUTIONS LTD
8 patents
- Applied Stemcell
APPLIED STEMCELL, INC.
8 patents
- Apricorn
APRICORN
8 patents
- Aptar Italia S P A
APTAR ITALIA S.P.A.
8 patents
- Ariagen
ARIAGEN, INC.
8 patents
- Aries Gasification
ARIES GASIFICATION, LLC
8 patents
- ARIX
ARIX TECHNOLOGIES, INC.
8 patents
- ARK
ARK LIMITED
8 patents
- Aramis Biotechnol… ◀
ARAMIS BIOTECHNOLOGIES INC.
8 patents
What this shows Aramis holds 8 patents at rank #30,790, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Aramis
By rank, the assignees closest to #30,790 in granted patent volume.
- APM Automation Solutions Ltd #30,786 · 8 patents
- Applied Stemcell, Inc. #30,787 · 8 patents
- Apricorn #30,788 · 8 patents
- Aptar Italia S.p.a. #30,789 · 8 patents
- Ariagen, Inc. #30,791 · 8 patents
- Aries Gasification, Llc #30,792 · 8 patents
- ARIX Technologies, Inc. #30,793 · 8 patents
- ARK Limited #30,794 · 8 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Aramis's primary technology class.
- Monsanto Technology Llc 1,335 in class
- The Regents Of The University Of California 1,161 in class
- Novozymes A/s 656 in class
- Immatics Biotechnologies Gmbh 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President And Fellows Of Harvard College 594 in class
- Massachusetts Institute Of Technology 541 in class
- The Trustees Of The University Of Pennsylvania 537 in class
Aramis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 7 | 87.5% |
| 2025 | 1 | 12.5% |
Which technologies does Aramis Biotechnologies Inc. patent most?
Top 6 of 6 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Frequently Asked Questions
How many patents does Aramis Biotechnologies Inc. hold?
Aramis Biotechnologies Inc. holds 8 US granted patents filed between 2024 and 2025, spanning 6 technology areas.
What is Aramis Biotechnologies Inc.'s Innovation Score?
Aramis Biotechnologies Inc. has an Innovation Score of 46.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Aramis Biotechnologies Inc. focus on?
Aramis Biotechnologies Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 8 patents. The company has filed patents in 6 CPC subclasses total.
Is Aramis Biotechnologies Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Aramis Biotechnologies Inc..
What does claim depth mean for Aramis Biotechnologies Inc.'s patents?
Aramis Biotechnologies Inc.'s patents average 17.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Aramis Biotechnologies Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Aramis's 8 grants land it in the top 21% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Aramis ranks #30,790 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.